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AbstrACt
Introduction Mental disorders represent the second 
cause of years lived with disability worldwide. Suicide 
mortality has been targeted as a key public health concern 
by the WHO. Smartphone technology provides a huge 
potential to develop massive and fast surveys. Given the 
vast cultural diversity of Mexico and its abrupt orography, 
smartphone- based resources are invaluable in order to 
adequately manage resources, services and preventive 
measures in the population. The objective of this study is 
to conduct a universal suicide risk screening in a rural area 
of Mexico, measuring also other mental health outcomes 
such as depression, anxiety and alcohol and substance 
use disorders.
Methods and analysis A population- based cross- 
sectional study with a temporary sampling space of 
9 months will be performed between September 2019 and 
June 2020. We expect to recruit a large percentage of the 
target population (at least 70%) in a short- term survey 
of Milpa Alta Delegation, which accounts for 137 927 
inhabitants in a territorial extension of 288 km2.
They will be recruited via an institutional call and a 
massive public campaign to fill in an online questionnaire 
through mobile- assisted or computer- assisted web app. 
This questionnaire will include data on general health, 
validated questionnaires including Well- being Index 5, 
Patient Health Questionnaire-9, Generalized Anxiety 
Disorder Scale 2, Alcohol Use Disorders Identification Test, 
selected questions of the Drug Abuse Screening Test and 
Columbia- Suicide Severity Rating Scales and Diagnostic 
and statistical manual of mental disorders (DSM-5) 
questions about self- harm.
We will take into account information regarding time 
to mobile app response and geo- spatial location, 
and aggregated data on social, demographical and 
environmental variables. Traditional regression modelling, 
multilevel mixed methods and data- driven machine 
learning approaches will be used to test hypotheses 
regarding suicide risk factors at the individual and the 
population level.
Ethics and dissemination Ethical approval (002/2019) 
was granted by the Ethics Review Board of the Hospital 
Psiquiátrico Yucatán, Yucatán (Mexico). This protocol has 
been registered in  ClinicalTrials. gov. The starting date 
strengths and limitations of this study
 ► Smartphone- screening (SMART- SCREEN) a popu-
lation’s mental health provides a novel approach to 
public health screening campaigns.
 ► Innovative methods using smartphone- based tech-
nology are an easy, cost- effective means to study-
ing suicidal ideation, depression and other mental 
health outcomes and risk factors.
 ► Mental health data will be explored along with other 
health- related questionnaires in a built- in smart-
phone app that will enhance data collection; how-
ever, a web- based version is already functional and 
access points located in educational and municipal 
facilities will be made available.
 ► SMART- SCREEN expects to recruit a large per-
centage of the target population (at least 70%) in a 
short- term cross- sectional survey. It will be powered 
by a local massive health campaign.
 ► This study has some limitations: access of people 
who do not own a smartphone is particularly con-
cerning. Probabilistic models will be used to handle 
data losses without biasing nor decreasing the va-
lidity of our results.
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of the study is 3 September 2019. Results will serve for the planning 
and healthcare of groups with greater mental health needs and will be 
disseminated via publications in peer- reviewed journal and presented at 
relevant mental health conferences.
trial registration number NCT04067063.
IntroduCtIon
According to the 2017 Global Burden of Disease (GBD) 
study, mental disorders represent the second cause of 
years living with disability (YLDs) worldwide.1 In partic-
ular, depression is the third leading cause of YLDs right 
after low back pain and headache disorders.2 Substance 
use disorders are also a leading cause of disability.1 The 
impact of depression and substance use disorders is 
similar in high- income and Latin American and Carib-
bean countries.3
Furthermore, mental disorders underlie most of cases 
of suicidal behaviour.4 5 Suicide is considered a key public 
health concern by the WHO4 and a sustainable develop-
ment indicator by the United Nations.5 Notably, deaths 
due to self- harm are irregularly distributed across the 
globe, with 79% of global suicides happening in low/
middle- income countries (LMICs).6 7 Suicide mortality 
is driven by a complex combination of risk and protec-
tive factors at the individual and the population levels, 
such as mental health and substance use disorders, access 
to lethal means or availability of proper healthcare and 
social welfare programmes and evidence- based interven-
tions. The prevalence of such factors, as well as their rela-
tive impact on suicide rates, varies over time and across 
populations. For example, while over 90% of suicides 
in western countries are related to mental health disor-
ders, this proportion does not exceed 50% in China8; 
and while many high income countries have experienced 
a recent increase in suicide mortality among middle- 
aged men, this phenomenon has not been detected in 
Southern Europe.9 Notwithstanding the need to account 
for regional variations in suicide risk factors and suicide 
mortality in order to appropriately impact suicide risk 
globally, most suicide research is conducted in high- 
income countries, where suicide risk is lowest.4
In Mexico, mental health issues represent a consider-
able proportion of the burden of disability, with depres-
sion and anxiety disorders ranking as the fifth and ninth 
leading causes of disability, respectively.10 In addition, 
suicide is the 15th leading cause of death in Mexico,11 
with particularly concerning rates among young men, and 
suicide mortality has increased alarmingly over the recent 
years. In a report based on the GBD estimates, Naghavi 
et al estimated that age- standardised suicide mortality of 
men and women combined have increased over a 20% 
between 1990 and 2016 in Mexico,12 and data from the 
National Institute of Statistics and Geography suggest 
that the steepest increases have taken place over the last 
decade—from 4.3 suicides per 100 000 in 2008 to 5.2 in 
2016.13 This is in contrast with global decreasing trends, 
driven by marked reductions in suicide mortality in China 
and India, but in line with recent increases in the USA.14
In Mexico, suicide attempts have an annual preva-
lence of 0.7%15 for a total of over 900 000 annual suicide 
attempts that entail a substantial burden for the Mexican 
Health System.16 Despite these large numbers, insuffi-
cient mental health services are available and large gaps 
exists in mental healthcare17; less than 30% of people 
who die by suicide in Mexico have received mental health 
treatment over the previous year and less than 20% of 
individuals with depression seek help from mental health-
care providers.18
In the current moment of emergence of e- health and 
m- health,19 smartphones serve as a readily available tool 
for data collection20 21 and universal screening and inter-
vention.22–28 Mobile technology entails huge potential 
for the development of massive fast surveys, allowing for 
the collection of even more information than is explicitly 
asked, such as geographic location via global positioning 
system.29 30 Thus, smartphones could be useful in epide-
miological surveys, which are the base for healthcare 
planning and resource allocation. Recently, a nation- wide 
survey protocol was published that included smartphone- 
collected data from all residents of the Netherlands and 
looked at their exposure to environmental factors that 
could affect mental health outcomes such as depression 
and suicide risk.20 However, this survey relies on strati-
fied representative sampling, and therefore it cannot be 
considered a universal community screening. Addition-
ally, also in the Netherlands, a national crowdsourcing 
study investigated multiple mental health dimensions in 
a sample from the general population (n=12 503).31 In 
rural Guatemala similar smartphone- based methods have 
been used to estimate the burden of acute gastroenteritis 
and norovirus, using a sample of around 400 children 
covering an area of 200 km2 over 6 months.32 It should be 
noted that, to date, no study has tried to cover an entire 
community in a systematic way.
Given the vast cultural diversity of Mexico and 
its numerous communities and abrupt orography, 
smartphone- based assessments are invaluable in order 
to manage healthcare resources and administer preven-
tive measures. Furthermore, practically the entire 
Mexican population owns a mobile phone and 83.8% of 
mobile phone owners have a smartphone, representing 
69,9 million people.33 Regarding mental health, smart-
phones can be useful for the development of epidemio-
logical or screening surveys and also to optimise existent 
resources. Of note, most countries, including Mexico, 
have less than two psychiatrists per 100 000 people.34
The objective of this study is to conduct a universal 
screening of suicidal ideation, depression, anxiety 
and alcohol and substance use in a large rural area of 
Mexico. Our working hypothesis is that that this universal 
screening based on a smartphone app can identify 
people at risk across the whole community. Data from 
this screening should serve to depict a map of the mental 
health and related needs of the population that can 
inform local healthcare planning. This map will be useful 
to improve assistance to groups and individuals at greatest 
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Figure 1 Gantt chart smartphone- screening study.
Table 1 Population aged 18 years and over living in each 
of the Milpa Alta Delegation municipalities according to the 




















We will implement a population- based cross- sectional 
study with a temporary sampling space of 9 months. The 
study design will follow the Strengthening the Reporting 
of Observational Studies in Epidemiology statement.35 
Figure 1 depicts the study phases as a Gantt diagram.
study population and sampling design
The Milpa Alta Delegation is located at the southern end 
of Mexico City. It has a territorial extension of 288 km2, 
divided in nine municipalities. Its estimated population 
is 137 927 inhabitants, according to the 2015 intercensal 
survey, with roughly 92 000 individuals aged between 15 
and 69 years old.36 Table 1 depicts the distribution of 
population aged ≥18 years in each of the nine municipal-
ities that form the Milpa Alta Delegation. Importantly, 
the Milpa Alta Delegation has one regional hospital 
with a sole psychiatrist (PEAC). The nearest psychiatric 
hospital and mental health department are 3 hours away 
by car.
As we aimed at recruiting the whole population in a 
single survey study in less than 1 year, no sampling proce-
dure was established.
Our inclusion criteria are as follows: (1) being between 
15 and 70 years old; (2) being able to use a smartphone 
or a computer, either using their own smartphone or 
computers enabled by local government at the Milpa Alta 
Delegation or by local education services at educational 
centres; (3) being able to understand the nature, purpose 
and methodology of the study; (4) accepting participa-
tion in the study and checking the corresponding box 
in the app that verifies that informed consent has been 
expressly given.
Exclusion criteria are: (1) being deprived of liberty 
(by judicial or administrative decision) and (2) being 
protected by law (eg, being under guardianship).
The rationale behind including the entire population 
is based on the main objective of the study: performing 
a population screening. We expect a response rate of, at 
least, 70% of the population between 15 and 70 years old; 
primarily, from their own smartphone. To achieve higher 
rates and avoid discrimination based on age or access to 
technology37 web access devices will be enabled for public 
use in educational and municipal facilities.
survey
Starting September 2019, all Milpa Alta inhabitants are 
being invited via an institutional call and a massive public 
campaign to fill in an online questionnaire through 
mobile- assisted or computer- assisted web apps.
The survey will be carried out in three sequential 
phases:
1. Preparation phase, prior to any recruitment. A few cit-
izens will be asked for pilot- testing of the survey’s cul-
tural competence.
2. A first official recruitment period aimed at young pop-
ulation (aged 15–24 years) conducted within the edu-
cational institutions of Milpa Alta.
3. A second official recruitment period aimed at adult 
population (aged more than 18 years) of the Milpa 
Alta Delegation.
After fulfilling the questionnaire, each participant will 
receive a report including a global assessment of their 
responses unless they did not authorise it previously. 
Together with the report they will be sent a brief ques-
tionnaire to retrieve their opinion regarding their overall 
experience with the study procedure. In the event that 
the participant has a high risk of psychopathology, suicide 
and/or addiction, a priority appointment at a mental 
healthcare centre will be recommended and facilitated 
via an app message or e- mail, ensuring anonymity at all 
times.
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Figure 2 MeMind screenshots.
strategies to enhanced participation
Participation will be enhanced by several multilevel strat-
egies before starting recruitment periods:
1. The mayor’s office will disseminate the survey through 
posters in public places and health institutions, and ad-
vertisements will be placed in regional media websites 
(press conference prior to start the recruitment).
2. Local educational institutions will encourage partici-
pation of the student community through talks held 
annually at the beginning of the official school year.
3. Members of the suicide prevention programme of Mil-
pa Alta will coordinate procedures for local dissemi-
nation in each Milpa Alta Delegation municipality in 
collaboration with local representatives and communi-
ty leaders.
4. During the recruitment period, data on study partici-
pation will be collected in real time. If participation is 
observed to be lower than expected in specific munici-
palities or sociodemographic groups, additional infor-
mative measures will be adopted.
smartphone app
All assessments will be carried out using the MeMind 
smartphone app (Android and iOS) (figure 2) or the 
MeMind web app (https:// frontend. memind. net). This 
app is in use since 2014 and was developed to enhance 
access to clinical information for mental healthcare 
professionals and patients, with both clinical manage-
ment and research purposes.38 39 The MeMind app is 
programmed to send anonymous reports to participants, 
via the app or registration through e- mail, in an auto-
matic procedure that requires no active intervention by 
professionals and is compliant with the recommendations 
of mental healthcare professionals.
Participants will complete a built- in questionnaire 
composed of three generals question about health (body 
mass index, diabetes mellitus and prescribed treatment) 
and several psychometric instruments:
 ► The Well- being Index (WHO-5) scale is widely imple-
mented both in mental health and general health 
surveys. It has demonstrated adequate validity as a 
screening tool for depression and as a measure of clin-
ical response to interventions in various clinical trials 
in several countries including Mexico.40
 ► The Patient Health Questionnaire-9 is a self- 
administered questionnaire used to screen depres-
sion. It consists of nine items based on the Diagnostic 
and statistical manual of mental disorders (DSM- IV) 
diagnostic criteria for depression. In the Mexican 
population, the questionnaire was tested in 55 000 
women from the Mexican Teachers’ Cohort, showing 
high internal consistency with a Cronbach’s alpha of 
0.89.41
 ► The Generalized Anxiety Disorder Scale (GAD)-2 is 
an abbreviated version of GAD-7 which is a widely 
used anxiety screening instrument.42–44
 ► A short version of the Alcohol Use Disorders Identifi-
cation Test (AUDIT- C) will be used to assess alcohol 
use.45 46 This version will consist of the three first 
items of the AUDIT.46 We will seek to identify risk use 
patterns (alcohol misuse), using as threshold a score 
greater or equal to 5 in men and 4 in women.
 ► Three questions selected from the Drug Abuse 
Screening Test questionnaire will be used to assess 
the use of substances and their impact. These ques-
tions correspond with the screening part of the 
questionnaire.47
 ► The Columbia- Suicide Severity Rating Scale (C- SSRS)48 
is widely used for the study of suicidal behaviours and 
has demonstrated good sensitivity and specificity iden-
tifying the highest risk states for suicide.49 It has been 
translated and culturally adapted for the Mexican 
population.
 ► Two additional questions about self- harm adapted 
from DMS 5.50
outcomes
Our main outcomes will be participation rate (eg, 
sampling coverage with respect to the population), rate 
of evaluations completed correctly and, if participation 
rate is lower than 80%, level of representativeness of the 
sample.
Secondary outcomes will include the following: (1) esti-
mated prevalence of suicidal behaviours as measured by 
C- SSRS, depression, anxiety and alcohol and substance 
use disorders; (2) intensity of suicidal ideation and 
severity of self- injurious and/or suicidal behaviours; (3) 
quality of life of the population measured as measured 
by the WHO-5 scale and (4) profiles and clustering of 
comorbid mental- health problems within the population.
statistical analyses and result summaries for stakeholders
The statistical analysis has been designed considering 
four periods (table 2). During the recruitment phase, 
we will collect and process data in order to run real- time 
analyses and obtain key performance metrics that include 
the following domains: recruitment rate, representative-
ness, access and quality of data. Estimating the screening 
representativeness and coverage is key, as this study aims 
at universally screening all the population of Milpa Alta. 
Our hypothesis is that representativeness will be high, 
especially among youth.
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Table 2 Analysis, products and dissemination strategy
Period Recruitment End of recruitment One week after Two weeks after




Task  ► Monitoring
 ► Determination 
of relevant key 
performance 
indicators (KPIs)
 ► Use KPIs for increase 
recruitment
 ► Mapping of disorders
 ► Description procedures
 ► Cut- off point 
determination
 ► Pattern analysis
 ► Cluster analysis
  
 ► Design of participant- 
friendly reports
 ► Explain outliers





 ► Recruitment rate
 ► Representativeness
 ► Access
 ► Data quality 
assessment
 ► Representativeness





 ► Inaccessible population




 ► Rate of referral to mental 
healthcare providers
Products  ► Key performance 
metrics (KPM)
 ► Recommendations for 
the extension of this 
kind of surveys to other 
communities
 ► Reports for 
different community 
stakeholders
 ► Personal report for 
participants
Final results KPM for an extended 
survey
Information for the design of 
rapid surveys in communities 
using smartphones
Information for the design 
of preventive measures in 
the community
Detect untreated severe 
cases and refer them to the 
healthcare system
The use of questionnaires via smartphone allows for 
recording response times. This measure can be useful 
to estimate the degree of honesty of the participants’ 
honesty.
We will conduct descriptive analyses based on demo-
graphical and clinical data, including responses to ques-
tionnaires, in order to estimate the prevalence of positive 
screenings for each of the studied conditions. In addi-
tion, building on these data as well as on information 
regarding time to mobile app response and geo- spatial 
localisation, and aggregated data on social, demograph-
ical and environmental variables from the included loca-
tions, we will combine traditional regression methods 
with multilevel mixed methods and data- driven, machine 
learning approaches to test hypotheses regarding suicide 
risk factors at the individual and the population level. This 
will allow us to conduct a series of studies nested within 
the main research proposal that will greatly increase our 
understanding of suicide risk in Mexico.
Patient and public involvement
The study includes support by an advisory group 
comprised by a sample of people from the source popula-
tion, which met with the research team during the earlier 
stages of the study. This advisory group provided input to 
the programme of research, giving feedback on question-
naire content and length and reflecting on their overall 
experience with the screening process under study. In 
addition, members of the advisory group contributed 
informally and on their own initiative to the dissemina-
tion plan.
EthICs, dAtA MAnAgEMEnt And dIssEMInAtIon
Ethical review
The project will be conducted in accordance with the 
Declaration of Helsinki of the World Medical Association 
on ethical principles for medical research in humans, 
as well as with all requirements established in Mexico’s 
laws on data protection.51 Ethical approval (002/2019) 
was granted by the Ethics Review Board of the Hospital 
Psiquiátrico Yucatán, Yucatán (Mexico).
All personal data necessary for the development of the 
study are subject to the Mexican legislation. Each patient 
participating in the study will be anonymised and identi-
fied with a code. No data that may lead to the identifica-
tion of the participants in the study will be published in 
any of the works derived from this research.
There is no cost or financial compensation for partic-
ipating in this study: all interviews and tests will be 
conducted at no cost, and participants will not obtain 
any financial compensation, except for the benefits that 
derive from obtaining personal mental health reports 
and the overall improvement of healthcare planning that 
may stem from the study.
The only risk that may derive from the study is related 
the clinical evaluation. However, ecological momentary 
assessments are commonly used for the evaluation of 
patients and do not represent significant risks for subjects. 
Previous studies have shown that repeated patient ques-
tioning, including questions regarding suicidal ideation, 
does not lead to an increased risk of suicide.52 If a partic-
ipant is rated as being at high risk of suicide, MeMind 
will send him/her information regarding the nearest 
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psychiatric facility, as well as an emergency telephone 
number. To ensure anonymity, this is an automatised 
procedure.
Before accessing the questionnaire, each participant 
will have to provide consent to participate in the study 
after reading the study’s information and consent form. 




Data will be processed within a secure information tech-
nology environment, as stated above. Strategies for data 
security and protection are in compliance with Mexican 
law and European regulations. Participants will take the 
survey voluntarily and will grant their permissions before 
any data are gathered.
The database will not contain any identification data; 
hence, preserving responders’ complete privacy. The 
consumer web database is hosted on Amazon Web Services 
and all communications are encrypted using Hypertext 
Transfer Protocol Secure protocols and protected by 
security systems. There will be a summary record of all 
maintenance work performed (who/when/why/actions 
taken) as well as a record of all accesses to maintenance 
consoles (log files).
dissemination
We hope to achieve a scalable procedure throughout 
Mexico to generate a map of the mental health and needs 
of the population in local communities, which will serve 
for the planning and healthcare of groups with greater 
mental health needs.
In addition, results will be disseminated via publica-
tions in peer- reviewed journal and presented at relevant 
mental health conferences.
dIsCussIon
SMART- SCREEN is an innovative tool for mental health 
screening that has been specifically designed to explore 
and further understand the distribution of suicidal 
behaviours in the general population. This strategy 
enhances access to previously neglected rural communi-
ties and virtually does not need financial investment, as 
it builds on smartphone technology, currently of wide-
spread use in the population. This strategy is cheaper 
and faster than traditional epidemiological surveys and 
can be useful to fill the gap regarding suicide behaviours, 
especially in understudied populations such as LMICs. 
Of note, although many LMIC have usually less health 
resources than upper- middle income countries, smart-
phone penetrance is increasing rapidly worldwide. At the 
moment, the number of smartphone users have surpassed 
2 billion globally in 2016 and it is expected that there will 
be around 3 billion users by 2021.53
This project is a local initiative, with local stakeholders 
(municipalities government, educational institutions 
and mental health caregivers) directly involved in its 
implementation. Information provided by the survey will 
be useful in addition to the Psychiatric Epidemiologic 
National Survey that is conducted every year54 for mental 
healthcare planning and resource allocation. In addition, 
SMART- SCREEN will detect and refer people at risk to 
current mental health facilities with no need for increases 
in available resources and, in fact, will optimise access 
to mental healthcare among underserved people with 
mental health needs. If the project is successfully devel-
oped, and we achieve our participation goals, the epide-
miological information yielded will be representative and 
of incredible value. Furthermore, this methodology can 
be transported to others settings and used to screen a 
variety of health conditions. Finally, SMART- SCREEN can 
be a critical tool for the redefinition of mental healthcare 
policies.
SMART- SCREEN is intended to not only be a screening 
system but also to integrate personalised preventive 
actions. Participants who screen positive for mental health 
risk can receive individual- level healthcare recommenda-
tions, referral vouchers for local mental healthcare facil-
ities and so on. For instance, two of the most successful 
preventive strategies for suicide behaviours, the WHO’s 
brief intervention and contact intervention,55 and the 
safety planning intervention,56 can be easily incorporated 
to SMART- SCREEN.
SMART- SCREEN will be the first smartphone- based 
epidemiological survey covering an entire population, as 
most traditional surveys and even current smartphone- 
based projects instead use population samples.20 32 The 
whole population will be assessed using easy to under-
stand and validated instruments, real- time analyses 
will be conducted and quick feedback information will 
be reported to local health stakeholders and also to 
participants.
The main strength of this project is its innovative 
nature and its feasibility: the technology we will use in 
the SMART- SCREEN initiative has been previously used 
with success in clinical populations with mental disorders, 
achieving large sample sizes.57–60 We are concerned that 
difficulties in access to SMART- SCREEN among people 
who do not have a smartphone, as well as among the 
elderly, may somewhat undermine our study. We hope 
to overcome this limitation with the involvement of local 
administrations and community leaders, who will dissem-
inate the project and provide assisted computer stations 
in educational and municipal facilities. Other potential 
limitations include difficulties to achieve population 
representativeness, especially in the event that we achieve 
low participation rates, and the possibility of collecting 
low- quality, untruthful or missing data; to overcome these 
potential limitations we have selected widely demon-
strated usefulness self- reported questionnaires and we will 
also use probabilistic models that allow us to handle data 
losses without introducing bias or lowering the validity 
of our analyses. Finally, we have chosen short forms of 
all questionnaires to avoid overwhelming participants: 
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notably, we have successfully used questionnaires with a 
similar length in similar, previous studies.58
The SMART- SCREEN project pushes the boundaries of 
psychiatric scientific knowledge by allowing for massive 
population detection of suicide risk and mental health 
disorders using current state of the art technologies. 
Furthermore, SMART- SCREEN is a cost- effective tool 
for mental healthcare planning that enhances the inter-
action between mental health systems and underserved 
customers by making use of common, inexpensive and 
widespread technology. Our study will serve as an example 
for other large, comprehensive health assessments, espe-
cially if they are deployed within large public healthcare 
systems from rural communities and/or LMIC.
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